Suramin blocks hepatitis C binding to human hepatoma cells in vitro

Journal of Medical Virology

Volumn 57, Issue 3, 1999, Pages 238-242

  Garson, J A ^a   Lubach, D ^a   Passas, J ^a   Whitby, K ^a   Grant, P R ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

HCV; HepG2; Polyanions; Sulphated polysaccharides; Tissue culture

Indexed keywords

CHLOROFORM; CHONDROITIN 4 SULFATE; DEXTRAN SULFATE; HEPARIN; POLYANION; SURAMIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DENGUE VIRUS; FLAVIVIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; RNA ANALYSIS; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS DNA CELL DNA INTERACTION; VIRUS ENVELOPE; VIRUS INHIBITION;

CARCINOMA, HEPATOCELLULAR; CHLOROFORM; CULTURE MEDIA; HEPACIVIRUS; HUMANS; POLYSACCHARIDES; SULFATES; SURAMIN; TUMOR CELLS, CULTURED;

EID: 0032960676     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199903)57:3<238::AID-JMV5>3.0.CO;2-G     Document Type: Article

References (30)

1. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. 1979. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282:615-616.
2. Baba M, Pauwels R, Balzarini J, Arnout J, Desmyter J, Declercq E. 1988. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro. Proc Natl Acad Sci USA 85:6132-6136.
3. Bchini R, Capel F, Dauguet C, Dubanchet S, Petit M-A. 1990. In vitro infection of human hepatoma (HepG2) cells with hepatitis B virus. J Virol 64:3025-3032.
4. Braddock PS, Hu DE, Fan TPD, Stratford IJ, Harris AL, Bicknell R. 1994. A structure-activity analysis of antagonism of the growth factor and angiogenic activity of basic fibroblast growth factor by Suramin and related polyanions. Br J Cancer 69:890-898.
5. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulphate. Nat Med 3:866-871.
6. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
7. Coelen RJ, Jose DG, May JT. 1983. The effect of hexadimethrine bromide (polybrene) on the infection of the primate retroviruses SSV1/SSAV1 and BaEV. Arch Virol 75:307-311.
8. Cribier B, Schmitt C, Kirn A, Stoll-Keller F. 1998. Inhibition of hepatitis C virus adsorption to peripheral blood mononuclear cells by dextran sulphate. Arch Virol 143:375-379.
9. Elstein KH, Thomas DJ, Zucker RM. 1995. Factors affecting flow cytometric detection of apoptotic nuclei by DNA analysis. Cytometry 21:170-176.
10. Feinstone SM, Mihalik KB, Kamimura T, Alter HJ, London WT, Purcell-RH. 1983. Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform. Infect Immun 41:816-21.
11. Gherardi E, Thomas K, Le Cras TD, Fitzsimmons C, Moorby CD, Bowyer DE. 1992. Growth requirements and expression of LDL receptor and HMG-CoA reductase in HepG2 hepatoblastoma cells cultured in a chemically defined medium. Journal of Cell Science 103:531-539.
12. Goss SJ. 1993. A fresh look at the somatic cell genetics of hepatoma differentiation. J Cell Sci 104:231-235.
13. Gripon P, Diot C, Thézé N, Fourel I, Loreal O, Brechot C, Guguen-Guillouzo C. 1988. Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulphoxide. J Virol 62:4136-4143.
14. Grunt TW, Somnay C, Pavelka M, Ellinger A, Dittrich E, Dittrich C. 1991. The effects of dimethyl sulphoxide and retinoic acid on the cell growth and the phenotype of ovarian cancer cells. J Cell Sci 100:657-666.
15. Holodniy M, Kim S, Katzenstein D, Konrad M, Groves E, Merigan TC. 1991. Inhibition of human-immunodeficiency-virus gene amplification by heparin. J Clin Microbiol 29:676-679.
16. Iacovacci S, Saragiacomo M, Parolini I, Ponzetto A, Peschle C, Carloni G. 1993. Replication and multiplication of hepatitis C virus genome in human fetal liver cells. Res Virol 144:275-279.
17. Kobayashi K, Vokes EE, Vogelzang NJ, Janish L, Soliven B, Ratain MJ. 1995. Phase I study of Suramin given by intermittent infusion without adaptive control in patients with advanced cancer. J Clin Oncol 13:2196-2207.
18. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339:237-238.
19. Loke RH, Anderson MG, Coleman JC, Tsiquaye KN, Zuckerman AJ, Murray-Lyon IM. 1987. Suramin treatment for chronic active hepatitis B - toxic and ineffective. J Med Virol 21:97-99.
20. Meyers C, Frattini MG, Hudson JB, Laimins LA. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-972.
21. Moshage H, Yap SH. 1992. Primary cultures of human hepatocytes: a unique system for studies in toxicology, virology, parasitology and liver pathophysiology in man. J Hepatol 15:404-413.
22. Petcu DJ, Aldrich CE, Coates L, Taylor JM, Mason WS. 1988. Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus and hepatitis delta virus. Virology 167:385-392.
23. Schalm SW, Brouwer JT. 1997. Antiviral therapy of hepatitis C. Scand J Gastroenterol 32(Suppl S223):46-49.
24. Shimizu YK, Iwamoto A, Hijikata M, Purcell RH, Yoshikura H. 1992. Evidence of in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci USA 89:5477-5481.
25. Siepp S, Mueller HM, Pfaff E, Strermmel W, Theilman L, Goeser T. 1997. Establishment of persistent hepatitis C infection and replication in vitro. J Gen Virol 78:2467-2476.
26. Tagawa M, Kato N, Yokosuka O, Ishikawa T, Ohto M, Omata M. 1995. Infection of human hepatocyte lines with hepatitis C virus in vitro. J Gastroenterol Hepatol 10:523-527.
27. Tsiquaye KN, Collins P, Zuckerman AJ. 1986. Antiviral activity of the polybasic anion, Suramin and acyclovir in Hepadna virus infection. J Antimicrob Chemother 18(Suppl B):223-228.
28. Whitby K, Garson JA. 1997. A single tube two compartment RT-PCR system for the ultrasensitive quantitative detection of HCV-RNA. J Virol Methods 66:15-18.
29. Yahi N, Sabatier JM, Nickel P, Mabrouk K, Gonzalez-Scarano F, Fantini J. 1994. Suramin inhibits binding of the V3 region of HTV-1 envelope glycoprotein gp 120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. J Biol Chem 269:24349-24353.
30. Yang TT, Sinai P, Kain SE. 1996. An acid phosphatase assay for quantifying the growth of adherent and non-adherent cells. Anal Biochem 241:103-108.